Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OASMIA PHARMACEUTICAL AB (PUBL)

(OASM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OASMIA PHARMACEUTICAL AB (PUBL)
11/26Oasmia to present at the Erik Penser Bank Life Science Day on December 2
AQ
11/26Oasmia to present at Stora Aktiedagen Stockholm on December 2
AQ
11/12Invitation to presentation of Oasmia's Q3 report on November 18
AQ
11/11Invitation to presentation of Oasmia's Q3 report on November 18
AQ
10/21OASMIA PHARMACEUTICAL : announces global settlement of all disputes with MGC Capital, form..
AQ
10/20OASMIA PHARMACEUTICAL : Bulletin from Extraordinary General Meeting in Oasmia Pharmaceutic..
AQ
10/01OASMIA PHARMACEUTICAL : Naventus LifeScience Summit
PU
09/24OASMIA PHARMACEUTICAL : to present at Naventus Life Science Summit on September 29
AQ
09/20OASMIA PHARMACEUTICAL : Notice of Extraordinary General Meeting in Oasmia Pharmaceutical A..
AQ
09/17OASMIA PHARMACEUTICAL : signs agreement with FarmaMondo to commercialize Paclical® in Russ..
AQ
09/07OASMIA PHARMACEUTICAL : Presentation på Aktiedagen Stockholm
PU
08/31OASMIA PHARMACEUTICAL : to present at Aktiedagen Stockholm on September 7
AQ
08/26OASMIA PHARMACEUTICAL : strengthens internal capabilities with the appointments of Head of..
AQ
08/19OASMIA PHARMACEUTICAL : Interim report for the period January 1, 2021 – June 30, 202..
PU
08/11OASMIA PHARMACEUTICAL : First Patient enrolled in the SAKK Investigator-Initiated Phase 1b..
AQ
08/10OASMIA PHARMACEUTICAL : Invitation to presentation of Oasmia's Q2 report on August 19
AQ
06/30OASMIA PHARMACEUTICAL : Cantrixil positive Phase I trial data published in the journal Can..
AQ
06/28OASMIA PHARMACEUTICAL : transfers Nordic commercialization rights for Apealea® to Inceptua
AQ
06/11OASMIA PHARMACEUTICAL : First Patient enrolled in the SAKK Investigator-Initiated Phase 1b..
AQ
06/10OASMIA PHARMACEUTICAL : First Patient enrolled in the SAKK Investigator-Initiated Phase 1b..
AQ
06/09OASMIA PHARMACEUTICAL : Provides a R&D Update on its Technology Platforms
AQ
06/02OASMIA PHARMACEUTICAL : to present at Aktiespararna's Småbolagsdagar on June 9
AQ
05/27OASMIA PHARMACEUTICAL : Report from Annual General Meeting in Oasmia Pharmaceutical AB
AQ
04/29OASMIA PHARMACEUTICAL : publishes Annual Report for 2020
AQ
04/27OASMIA PHARMACEUTICAL : Notice of Annual General Meeting in Oasmia Pharmaceutical AB
AQ
04/27OASMIA PHARMACEUTICAL : The Nomination Committee of Oasmia proposes Andrea Buscaglia as ne..
AQ
04/21OASMIA PHARMACEUTICAL : Phase 1b Trial of Oasmia's Docetaxel Micellar in Advanced Prostate..
AQ
04/21OASMIA PHARMACEUTICAL : Phase 1b Trial of Oasmia's Docetaxel Micellar in Advanced Prostate..
AQ
04/12OASMIA PHARMACEUTICAL : Abstract från slutliga fas I-data med Cantrixil på AACR årsmöte 20..
PU
04/12OASMIA PHARMACEUTICAL : Presents Cantrixil Final Phase I Data at the 2021 AACR Annual Meet..
AQ
04/09OASMIA PHARMACEUTICAL : Announces Conference Call to Present Cantrixil Final Phase I Data ..
AQ
04/01OASMIA PHARMACEUTICAL : Appoints Dr Reinhard Koenig as Chief Scientific Officer
AQ
03/29OASMIA PHARMACEUTICAL : to Present Cantrixil Final Phase I Data at the 2021 AACR Virtual A..
AQ
03/26OASMIA PHARMACEUTICAL : to Present Cantrixil Final Phase I Data at the 2021 AACR Virtual A..
AQ
03/24OASMIA PHARMACEUTICAL : wins sole rights to record patents in its own name and is awarded ..
AQ
03/24OASMIA PHARMACEUTICAL : European Patent Office Informs Oasmia of its Intention to Grant XM..
AQ
03/20OASMIA PHARMACEUTICAL : BioEurope Spring, Virtual
PU
03/04OASMIA PHARMACEUTICAL : and Karolinska Institutet to collaborate on the biological potenti..
AQ
03/03OASMIA PHARMACEUTICAL : and Karolinska Institutet to collaborate on the biological potenti..
AQ
03/01OASMIA PHARMACEUTICAL : acquires global development and commercialization rights for Cantr..
AQ
02/19OASMIA PHARMACEUTICAL : Year-end report for the shortened financial year May 1, 2020 &ndas..
PU
02/17OASMIA PHARMACEUTICAL : Invitation to presentation of Oasmia's Year-end report on February..
AQ
02/16OASMIA PHARMACEUTICAL : Invitation to presentation of Oasmia's Year-end report on February..
AQ
02/01OASMIA PHARMACEUTICAL : Appoints Dr. Heidi B. Ramstad as Chief Medical Officer
AQ
01/29OASMIA PHARMACEUTICAL : Appoints Dr. Heidi B. Ramstad as Chief Medical Officer
AQ
01/19OASMIA PHARMACEUTICAL : SEB Digital Healthcare Seminar Presentation
PU
2020OASMIA PHARMACEUTICAL : partner Elevar Therapeutics signs licensing agreement with Inceptu..
AQ
2020OASMIA PHARMACEUTICAL : Secures Valuable IP Rights in Australia and Brazil
AQ
2020OASMIA PHARMACEUTICAL : partner Elevar Therapeutics signs licensing agreement with Inceptu..
AQ
2020OASMIA PHARMACEUTICAL : Partner Elevar Provides an Update on Apealea Development Plans in ..
PU
2020OASMIA PHARMACEUTICAL : Interim report for the period May 1, 2020 – October 31, 2020
PU
2020OASMIA PHARMACEUTICAL : Interim Report May – October 2020 – Report
PU
2020OASMIA PHARMACEUTICAL : Partner Elevar Provides an Update on Apealea Development Plans in ..
AQ
2020OASMIA PHARMACEUTICAL : Partner Elevar Provides an Update on Apealea Development Plans in ..
AQ
2020OASMIA PHARMACEUTICAL : Invitation to presentation of Oasmia's Q2 report on December 9
AQ
2020OASMIA PHARMACEUTICAL : appoints Robert Maiorana as acting CFO
PU
2020OASMIA PHARMACEUTICAL : appoints Robert Maiorana as acting CFO
AQ
2020OASMIA PHARMACEUTICAL : Nomination Committee appointed for the 2021 Annual General Meeting..
PU
2020OASMIA PHARMACEUTICAL : Nomination Committee appointed for the 2021 Annual General Meeting..
AQ
2020OASMIA PHARMACEUTICAL : Investival Showcase 11-16 November 2020, Virtual Conference
PU
2020OASMIA PHARMACEUTICAL : to present at Investival Showcase November 11-16
AQ
2020OASMIA PHARMACEUTICAL : to present at Investival Showcase November 11-16
PU
2020OASMIA PHARMACEUTICAL : to present at Investival Showcase November 11-16
AQ
2020OASMIA PHARMACEUTICAL : BIO-Europe®, Virtual Conference
PU
2020OASMIA PHARMACEUTICAL : Secures Important IP Rights
AQ
2020OASMIA PHARMACEUTICAL : Secures Important IP Rights
PU
2020OASMIA PHARMACEUTICAL : Secures Important IP Rights
AQ
2020OASMIA PHARMACEUTICAL : to present at Bio Europe Digital on October 26-29
AQ
2020OASMIA PHARMACEUTICAL : to present at Bio Europe Digital on October 26-29
PU
2020OASMIA PHARMACEUTICAL : to present at Bio Europe Digital on October 26-29
AQ
2020OASMIA PHARMACEUTICAL : The Disciplinary Committee of Nasdaq Stockholm orders Oasmia to pa..
AQ
2020OASMIA PHARMACEUTICAL : Erik Penser Cancer Day Presentation
PU
2020OASMIA PHARMACEUTICAL : partner Elevar Therapeutics signs agreement with Taiba Middle East..
AQ
2020OASMIA PHARMACEUTICAL : partner Elevar Therapeutics signs agreement with Taiba Middle East..
PU
2020OASMIA PHARMACEUTICAL : partner Elevar Therapeutics signs agreement with Taiba Middle East..
AQ
1  2  3  4Next
Upcoming event on OASMIA PHARMACEUTICAL AB (PUBL)